LONDON (Alliance News) - Hikma Pharmaceuticals PLC Thursday said Darhold Ltd, a company that some of its directors are interested in, purchased 150,000 shares at a price of 2,162.0 pence per share.
Chairman and Chief Executive Said Darwazah is a shareholder in Darhold with an equity interest of 21.49%, Executive Vice Chairman Mazen Darwazah holds a 10.82% stake and Non-executive Director Mohammed Al-Husry has a 7.95% stake.
All three are also directors of Darhold.
Hikma did not reveal the stake held by the individual directors nor Darhold following the transaction.
Hikma shares closed down 1.3% to 2,148.35 pence per share on Thursday.
By Joshua Warner; joshuawarner@alliancenews.com; @JoshAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Hikma Pharmaceuticals (HIK)